ECSP099086A - Comprimido masticable que contiene fenilefrina - Google Patents
Comprimido masticable que contiene fenilefrinaInfo
- Publication number
- ECSP099086A ECSP099086A EC2009009086A ECSP099086A ECSP099086A EC SP099086 A ECSP099086 A EC SP099086A EC 2009009086 A EC2009009086 A EC 2009009086A EC SP099086 A ECSP099086 A EC SP099086A EC SP099086 A ECSP099086 A EC SP099086A
- Authority
- EC
- Ecuador
- Prior art keywords
- phenylephrine
- tablet containing
- chewable tablet
- composition
- containing phenylephrine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se suministra una composición farmacéutica masticable que comprende fenilefrina, endulzante artificial, y una matriz sustancialmente libre de aldehído. La composición tiene estabilidad de fenilefrina adecuada para un producto comercial típico con dos años de vida de almacenamiento. Un método de elaboración de la composición y también se suministra un método de uso.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/492,656 US9005652B2 (en) | 2006-07-25 | 2006-07-25 | Chewable tablet containing phenylephrine |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP099086A true ECSP099086A (es) | 2009-02-27 |
Family
ID=38617929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2009009086A ECSP099086A (es) | 2006-07-25 | 2009-01-23 | Comprimido masticable que contiene fenilefrina |
Country Status (16)
Country | Link |
---|---|
US (2) | US9005652B2 (es) |
EP (1) | EP2043619A2 (es) |
JP (1) | JP2009544699A (es) |
KR (1) | KR20090033390A (es) |
CN (1) | CN101505738A (es) |
AU (1) | AU2007277314A1 (es) |
BR (1) | BRPI0715536A2 (es) |
CA (1) | CA2658629C (es) |
CO (1) | CO6180502A2 (es) |
EC (1) | ECSP099086A (es) |
IL (1) | IL196668A0 (es) |
MX (1) | MX2009000931A (es) |
RU (1) | RU2009103636A (es) |
SG (1) | SG173410A1 (es) |
WO (1) | WO2008013710A2 (es) |
ZA (1) | ZA200900565B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101464771B1 (ko) * | 2006-06-01 | 2014-11-26 | 머크 샤프 앤드 돔 코포레이션 | 페닐에프린의 지속 방출용 약제학적 조성물 |
NZ573174A (en) * | 2006-06-01 | 2012-01-12 | Msd Consumer Care Inc | Sustained release pharmaceutical dosage form containing phenylephrine |
BRPI0712532A2 (pt) * | 2006-06-01 | 2013-04-02 | Schering Plough Healthcare Prod Inc | formulaÇÕes e composiÇÕes farmacÊuticas de fenilefrina para absorÇço colânica |
TW200808376A (en) * | 2006-06-01 | 2008-02-16 | Schering Corp | Phenylephrine pulsed release formulations and pharmaceutical compositions |
BRPI0812784A2 (pt) * | 2007-06-01 | 2014-12-02 | Schering Plough Healthcare | Composição farmacêutica compreendendo um substrato e um revestimento contendo um ingrediente ativo e polivinilálcool |
CN101868253A (zh) * | 2007-11-21 | 2010-10-20 | 宝洁公司 | 可用于咳嗽治疗的制剂、方法和试剂盒 |
PE20091084A1 (es) * | 2007-12-07 | 2009-07-23 | Schering Plough Healthcare | Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal |
CA2802362C (en) * | 2010-06-11 | 2017-11-21 | Gm Pharmaceuticals, Inc. | Pharmaceutical compositions for alleviating upper respiratory and oral-pharyngeal congestion |
PL2956120T3 (pl) | 2013-02-13 | 2020-08-10 | The Procter & Gamble Company | Leki o smaku anyżu |
WO2015023675A2 (en) | 2013-08-12 | 2015-02-19 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
CN104434868A (zh) * | 2013-09-18 | 2015-03-25 | 重庆圣华曦药业股份有限公司 | 一种稳定且利于在消化道溶出的屈昔多巴口服剂型 |
US10172797B2 (en) | 2013-12-17 | 2019-01-08 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
WO2015137829A1 (en) * | 2014-03-12 | 2015-09-17 | Angeles Relinda G | Stable and palatable liquid pharmaceutical composition of phenylephrine and a maleate salt of an antihistamine |
CA2955229C (en) | 2014-07-17 | 2020-03-10 | Pharmaceutical Manufacturing Research Services, Inc. | Immediate release abuse deterrent liquid fill dosage form |
JP2017531026A (ja) | 2014-10-20 | 2017-10-19 | ファーマシューティカル マニュファクチュアリング リサーチ サービシズ,インコーポレーテッド | 徐放性乱用抑止性液体充填剤形 |
CN104983732B (zh) * | 2015-05-28 | 2018-05-04 | 华润三九医药股份有限公司 | 一种布洛肾素那敏片及其制备方法 |
AU2017331369B2 (en) | 2016-09-26 | 2019-11-21 | The Procter & Gamble Company | Extended relief dosage form |
US20210378990A1 (en) * | 2020-06-06 | 2021-12-09 | Gm Pharmaceuticals, Inc. | Compositions containing chlophedianol and menthol |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US928264A (en) | 1904-01-07 | 1909-07-20 | Nat Machine Co | Tire-setter. |
US3039922A (en) | 1959-08-17 | 1962-06-19 | Carter Prod Inc | Method of administering tablets having decongestant and anti-histaminic activity |
US3400197A (en) | 1965-01-26 | 1968-09-03 | Robins Co Inc A H | Compressible sustained release pharmaceutical tablet lipid-colloidal silica gel matrix fragment granules |
US3629394A (en) | 1969-10-13 | 1971-12-21 | William E Gaunt | Pleasant tasting chewable tablets and their production |
US4632821A (en) | 1983-07-20 | 1986-12-30 | Warner-Lambert Company | Magnesium trisilicate suitable for preparation of medicament adsorbates of decongestants |
US4753800A (en) | 1985-10-04 | 1988-06-28 | Warner-Lambert Company | Medicament adsorbates and their preparation |
US4942236A (en) | 1987-09-30 | 1990-07-17 | American Home Products Corporation | 2-aryl substituted pyridyl-containing phenyl sulfonamido compounds as antiallergic and antiinflammatory agents |
US5013716A (en) * | 1988-10-28 | 1991-05-07 | Warner-Lambert Company | Unpleasant taste masking compositions and methods for preparing same |
US4946684A (en) | 1989-06-20 | 1990-08-07 | American Home Products Corporation | Fast dissolving dosage forms |
AU670567B2 (en) | 1992-03-05 | 1996-07-25 | American Home Products Corporation | Pharmaceutical coated cores |
US5348747A (en) | 1992-03-05 | 1994-09-20 | American Home Products Corporation | Pharmaceutical coating sugars |
NZ267002A (en) * | 1993-06-04 | 1997-07-27 | Warner Lambert Co | Chewable cold/sinus relief preparation comprising antihistamine and decongestant in a carrier consisting of silicon dioxide |
GB9422571D0 (en) | 1994-11-09 | 1995-01-04 | Whitehall Lab Ltd | Haemorrihoidal compositions and method of use |
TW580397B (en) | 1997-05-27 | 2004-03-21 | Takeda Chemical Industries Ltd | Solid preparation |
EP0901787B1 (en) | 1997-09-10 | 2003-05-28 | Takeda Chemical Industries, Ltd. | Stabilized pharmaceutical composition |
WO2003009834A1 (en) | 2000-08-17 | 2003-02-06 | Battey Alyce S | Oral delivery of pharmaceuticals via encapsulation |
GB0028575D0 (en) | 2000-11-23 | 2001-01-10 | Elan Corp Plc | Oral pharmaceutical compositions containing cyclodextrins |
US6869618B2 (en) * | 2001-04-10 | 2005-03-22 | Kiel Laboratories, Inc. | Process for preparing tannate liquid and semi-solid dosage forms |
MXPA04001026A (es) | 2001-07-31 | 2005-06-20 | Wyeth Corp | Formulacion de sucralosa para disimular sabores desagradables. |
US6509492B1 (en) | 2001-08-31 | 2003-01-21 | First Horizon Pharmaceutical Corporation | Tannate compositions and methods of treatment |
US20030060422A1 (en) | 2001-08-31 | 2003-03-27 | Balaji Venkataraman | Tannate compositions and methods of treatment |
US20030083354A1 (en) * | 2001-10-26 | 2003-05-01 | Pediamed Pharmaceuticals, Inc. | Phenylephrine tannate and pyrilamine tannate salts in pharmaceutical compositions |
JP3987501B2 (ja) | 2003-02-19 | 2007-10-10 | ロート製薬株式会社 | 医薬組成物 |
WO2006064327A1 (en) | 2004-12-13 | 2006-06-22 | Mcneil-Ppc, Inc. | Compositons and methods for stabilizing active pharmaceutical ingredients |
US10022339B2 (en) * | 2006-04-21 | 2018-07-17 | The Procter & Gamble Company | Compositions and methods useful for treatment of respiratory illness |
NZ573174A (en) | 2006-06-01 | 2012-01-12 | Msd Consumer Care Inc | Sustained release pharmaceutical dosage form containing phenylephrine |
TW200808376A (en) | 2006-06-01 | 2008-02-16 | Schering Corp | Phenylephrine pulsed release formulations and pharmaceutical compositions |
JP5054966B2 (ja) * | 2006-12-20 | 2012-10-24 | ロート製薬株式会社 | 固形製剤 |
-
2006
- 2006-07-25 US US11/492,656 patent/US9005652B2/en active Active
-
2007
- 2007-07-18 BR BRPI0715536-0A patent/BRPI0715536A2/pt not_active IP Right Cessation
- 2007-07-18 WO PCT/US2007/016258 patent/WO2008013710A2/en active Application Filing
- 2007-07-18 JP JP2009521763A patent/JP2009544699A/ja active Pending
- 2007-07-18 RU RU2009103636/15A patent/RU2009103636A/ru not_active Application Discontinuation
- 2007-07-18 MX MX2009000931A patent/MX2009000931A/es unknown
- 2007-07-18 CN CNA2007800308913A patent/CN101505738A/zh active Pending
- 2007-07-18 CA CA2658629A patent/CA2658629C/en active Active
- 2007-07-18 EP EP07810561A patent/EP2043619A2/en not_active Ceased
- 2007-07-18 KR KR1020097003038A patent/KR20090033390A/ko not_active Application Discontinuation
- 2007-07-18 AU AU2007277314A patent/AU2007277314A1/en not_active Abandoned
- 2007-07-18 SG SG2011053295A patent/SG173410A1/en unknown
-
2009
- 2009-01-22 IL IL196668A patent/IL196668A0/en unknown
- 2009-01-23 CO CO09006117A patent/CO6180502A2/es not_active Application Discontinuation
- 2009-01-23 ZA ZA200900565A patent/ZA200900565B/xx unknown
- 2009-01-23 EC EC2009009086A patent/ECSP099086A/es unknown
-
2015
- 2015-03-10 US US14/643,441 patent/US20150182478A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN101505738A (zh) | 2009-08-12 |
BRPI0715536A2 (pt) | 2013-05-07 |
CO6180502A2 (es) | 2010-07-19 |
WO2008013710A3 (en) | 2008-07-24 |
IL196668A0 (en) | 2009-11-18 |
CA2658629A1 (en) | 2008-01-31 |
CA2658629C (en) | 2015-07-14 |
US20150182478A1 (en) | 2015-07-02 |
AU2007277314A1 (en) | 2008-01-31 |
MX2009000931A (es) | 2009-02-04 |
US9005652B2 (en) | 2015-04-14 |
RU2009103636A (ru) | 2010-08-27 |
US20080026055A1 (en) | 2008-01-31 |
WO2008013710A2 (en) | 2008-01-31 |
ZA200900565B (en) | 2009-12-30 |
EP2043619A2 (en) | 2009-04-08 |
SG173410A1 (en) | 2011-08-29 |
KR20090033390A (ko) | 2009-04-02 |
JP2009544699A (ja) | 2009-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP099086A (es) | Comprimido masticable que contiene fenilefrina | |
ES2524458T3 (es) | DNasa para el tratamiento de la subfertilidad masculina | |
ECSP088680A (es) | Arildihidroisoquinolinonas sustituidas con azaciclilo, procedimiento para su preparación y su uso como medicamentos | |
AR058433A1 (es) | Derivado de 1,1-dioxido de 1,4-benzotiazepina ,procedimiento para su preparacion ,medicamentos que comprenden este compuesto y su uso | |
ES2629749T3 (es) | Inmunidad tumoral | |
CL2012003625A1 (es) | Una composicion acuosa que contiene bromhexina, en donde la composicion tiene una cantidad de azucar-alcoholes inferior a 10 g referida a 100 ml de la composicion; y su uso para la terapia secretorica en enfermedades broncopulmonares agudas y cronicas. | |
UY30165A1 (es) | Nuevas arildihidroisoquinolinonas sustituidas con aminolcoholes, procedimiento para su preparación y su uso como medicamentos | |
CR8717A (es) | Nuevos compuestos | |
NI200500164A (es) | Nueva difenilazetidinona con caracteristicas fisiologicas mejoradas, correspondiente metodo de produccion, medicamentos que contienen dicho compuesto y su uso. | |
UY30484A1 (es) | Composiciones lequidas de fenilefrina de estabilidad mejorada. | |
CR7583A (es) | Nueva sal formiato de o-desmetil venlafaxina | |
BRPI0817154A2 (pt) | "método de modificar uma célula de levedura para a produção de etanol, célula de levedura modificada, uso de uma célula de levedura modificada e método para a produção de etanol" | |
ECSP088461A (es) | Composiciones farmacéuticas que contienen buprenorfina | |
UY31647A1 (es) | Forma de dosificación farmacéutica para la administración oral de inhibidor de tirosina quinasa | |
CL2007001391A1 (es) | Compuestos derivados de pirrolidinas sustituidas, inhibidores del factor xa y/o inhibidores sobre la serina proteasa; composicion farmaceutica que comprende a dichos compuestos; proedimiento para preparar la composicon farmaceutica; y uso de los compuestos preparar un medicamneto con un efecto antitrombotico | |
UY30164A1 (es) | Nuevas ariltienopirimidinonas sustituidas con aminoalcoholes, procedimiento para su preparación y su uso como medicamentos | |
CL2007001752A1 (es) | Compuesto 4-[5(2-amino-etansulfonil)-isoquinolin-7-il]-fenolo una sal farmaceuticamente aceptable o un hidrato o la sal del mismo;composicion farmaceutica que comprende a dicho compuesto,composicion farmaceutica liofilizada;y uso del compuesto como antineiplasico y/o antiviral. | |
ES2531516T3 (es) | Uso de escina | |
CL2008003006A1 (es) | Uso de ester metilico del acido (-)-(3ar,4s,7ar)-4-hidroxi-4-m-toliletinil-octahidro-indol-1-carboxilico en base libre o en forma de sal para el tratamiento, prevencion o retraso de la progresion de la disquinesia de parkinson asociada a l-dopa; uso de la composicion farmaceutica; uso de una composicion que ademas comprende l-dopa. | |
ECSP056186A (es) | Composición farmacéutica en forma de hidrogel para administración transdérmica de sustancias activas | |
UY32299A (es) | Composiciones farmacéuticas líquidas | |
SG162766A1 (en) | Benzooxazole-2-on derivatives as lipase and phospholipase inhibitors | |
UY27610A1 (es) | Combinación de inhibidores de ptm o inhibidores de la secreción de apob con fibratos para la utilización como medicamentos | |
MY146803A (en) | Benzothiazol-2-on derivatives as lipase and phospholipase inhibitors | |
CO2021011525A2 (es) | Composición farmacéutica que contiene acetaminofeno e ibuprofeno |